Kalp ve Damar Cerrahisi (Çocuk)
Hemostaz Yönetimi ve Hemostazın İyi Duruma Getirilmesi
Antifibrinolitik İlaçlar
Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. (yeni pencere açar)
Kaynak: Anesth Analg 2006;102(3):731-7.
İndeks: PubMed 16492820
DOI: 10.1213/01.ane.0000194954.64293.61
https://www.ncbi.nlm.nih.gov/pubmed/16492820 (yeni pencere açar)
A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use. (yeni pencere açar)
Kaynak: Pediatr Surg Int 2012;28(11):1059-69.
İndeks: PubMed 22940882
DOI: 10.1007/s00383-012-3167-6
https://www.ncbi.nlm.nih.gov/pubmed/22940882 (yeni pencere açar)
Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery. (yeni pencere açar)
Kaynak: Br J Anaesth 2012;108(5):830-7.
İndeks: PubMed 22362670
DOI: 10.1093/bja/aes002
https://www.ncbi.nlm.nih.gov/pubmed/22362670 (yeni pencere açar)
Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. (yeni pencere açar)
Kaynak: J Cardiothorac Vasc Anesth 2004;18(2):141-3.
İndeks: PubMed 15073700
https://www.ncbi.nlm.nih.gov/pubmed/15073700 (yeni pencere açar)
Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. (yeni pencere açar)
Kaynak: Ann Thorac Surg 2000;70(4):1308-12.
İndeks: PubMed 11081890
https://www.ncbi.nlm.nih.gov/pubmed/11081890 (yeni pencere açar)
The Bayer 022 compassionate-use pediatric study. (yeni pencere açar)
Kaynak: Ann Thorac Surg 1998;65(6 Suppl):S31-3.
İndeks: PubMed 9647135
https://www.ncbi.nlm.nih.gov/pubmed/9647135 (yeni pencere açar)
Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery. (yeni pencere açar)
Kaynak: J Thorac Cardiovasc Surg 2012;143(5):1069-76.
İndeks: PubMed 22075061
DOI: 10.1016/j.jtcvs.2011.08.051
https://www.ncbi.nlm.nih.gov/pubmed/22075061 (yeni pencere açar)
Minimizing perioperative blood loss and transfusions in children. [Réduire les pertes sanguines et les besoins transfusionnels en chirurgie pédiatrique.] [English, French abstract] (yeni pencere açar)
Kaynak: Can J Anaesth 2006;53(6 Suppl):S59-67.
İndeks: PubMed 16766791
https://www.ncbi.nlm.nih.gov/pubmed/16766791 (yeni pencere açar)
Intraoperative tranexamic acid in pediatric bloodless cardiac surgery. (yeni pencere açar)
Kaynak: Asian Cardiovasc Thorac Ann 2014;22(9):1039-45.
İndeks: PubMed 24637029
DOI: 10.1177/0218492314527991
https://www.ncbi.nlm.nih.gov/pubmed/24637029 (yeni pencere açar)
The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. (yeni pencere açar)
Kaynak: PLoS One 2015;10(5):e0126514.
İndeks: PubMed 25954976
DOI: 10.1371/journal.pone.0126514
https://www.ncbi.nlm.nih.gov/pubmed/25954976 (yeni pencere açar)
Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials. (yeni pencere açar)
Kaynak: Int J Clin Exp Pathol 2015;8(7):7978-87.
İndeks: PubMed 26339364
https://www.ncbi.nlm.nih.gov/pubmed/26339364 (yeni pencere açar)
Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. (yeni pencere açar)
Kaynak: Eur J Cardiothorac Surg 2011;39(6):892-7.
İndeks: PubMed 21115357
DOI: 10.1016/j.ejcts.2010.09.041
https://www.ncbi.nlm.nih.gov/pubmed/21115357 (yeni pencere açar)
Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome. (yeni pencere açar)
Kaynak: Br J Anaesth 2013;110(4):615-21.
İndeks: PubMed 23213034
DOI: 10.1093/bja/aes430
https://www.ncbi.nlm.nih.gov/pubmed/23213034 (yeni pencere açar)
Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (yeni pencere açar)
Kaynak: Ann Thorac Surg 1998;66(2):535-40; discussion 541.
İndeks: PubMed 9725399
https://www.ncbi.nlm.nih.gov/pubmed/9725399 (yeni pencere açar)
Efficacy of tranexamic acid as compared to aprotinin in open heart surgery in children. (yeni pencere açar)
Kaynak: Ann Card Anaesth 2015;18(1):23-6.
İndeks: PubMed 25566706
DOI: 10.4103/0971-9784.148316
https://www.ncbi.nlm.nih.gov/pubmed/25566706 (yeni pencere açar)
Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (yeni pencere açar)
Kaynak: J Thorac Cardiovasc Surg 2012;143(3):550-7.
İndeks: PubMed 22264414
DOI: 10.1016/j.jtcvs.2011.06.048
https://www.ncbi.nlm.nih.gov/pubmed/22264414 (yeni pencere açar)
The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. (yeni pencere açar)
Kaynak: Anesth Analg 1997;84(5):990-6.
İndeks: PubMed 9141920
https://www.ncbi.nlm.nih.gov/pubmed/9141920 (yeni pencere açar)
Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study. (yeni pencere açar)
Kaynak: Eur J Anaesthesiol 2015;32(12):844-50.
İndeks: PubMed 26258658
DOI: 10.1097/EJA.0000000000000316
https://www.ncbi.nlm.nih.gov/pubmed/26258658 (yeni pencere açar)
Comparison of different doses of ε-aminocaproic acid in children for tetralogy of Fallot surgery: clinical efficacy and safety. (yeni pencere açar)
Kaynak: J Cardiothorac Vasc Anesth 2013;27(1):23-9.
İndeks: PubMed 22995453
DOI: 10.1053/j.jvca.2012.07.001
https://www.ncbi.nlm.nih.gov/pubmed/22995453 (yeni pencere açar)
Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation. (yeni pencere açar)
Kaynak: Ann Card Anaesth 2010;13(2):110-5.
İndeks: PubMed 20442540
DOI: 10.4103/0971-9784.62935
https://www.ncbi.nlm.nih.gov/pubmed/20442540 (yeni pencere açar)
Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. (yeni pencere açar)
Kaynak: Anesthesiology 2015;122(4):746-58.
İndeks: PubMed 25585004
DOI: 10.1097/ALN.0000000000000570
https://www.ncbi.nlm.nih.gov/pubmed/25585004 (yeni pencere açar)
Efficacy and safety of aprotinin in neonatal congenital heart operations. (yeni pencere açar)
Kaynak: Ann Thorac Surg 2011;92(3):958-63.
İndeks: PubMed 21871283
DOI: 10.1016/j.athoracsur.2011.04.094
https://www.ncbi.nlm.nih.gov/pubmed/21871283 (yeni pencere açar)
The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. (yeni pencere açar)
Kaynak: J Thorac Cardiovasc Surg 1996;111(5):982-7.
İndeks: PubMed 8622323
https://www.ncbi.nlm.nih.gov/pubmed/8622323 (yeni pencere açar)
Rekombinant Aktive Faktör VII (rFVIIa)
Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. (yeni pencere açar)
Kaynak: Ann Thorac Surg 2007;84(1):161-8.
İndeks: PubMed 17588404
DOI: 10.1016/j.athoracsur.2007.02.051
https://www.ncbi.nlm.nih.gov/pubmed/17588404 (yeni pencere açar)
Pediatric off-label use of recombinant factor VIIa. (yeni pencere açar)
Kaynak: Pediatrics 2009;123(3):1066-72.
İndeks: PubMed 19255041
DOI: 10.1542/peds.2008-1685
https://www.ncbi.nlm.nih.gov/pubmed/19255041 (yeni pencere açar)
Factor VII for excessive bleeding following congenital heart disease surgery. (yeni pencere açar)
Kaynak: Asian Cardiovasc Thorac Ann 2012;20(2):120-5.
İndeks: PubMed 22499956
DOI: 10.1177/0218492311433614
https://www.ncbi.nlm.nih.gov/pubmed/22499956 (yeni pencere açar)
Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (yeni pencere açar)
Kaynak: Paediatr Anaesth 2009;19(4):364-70.
İndeks: PubMed 19143947
DOI: 10.1111/j.1460-9592.2008.02905.x
https://www.ncbi.nlm.nih.gov/pubmed/19143947 (yeni pencere açar)
Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. (yeni pencere açar)
Kaynak: Anesth Analg 2012;115(2):364-78.
İndeks: PubMed 22652310
DOI: 10.1213/ANE.0b013e31825aff10
https://www.ncbi.nlm.nih.gov/pubmed/22652310 (yeni pencere açar)
Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery? (yeni pencere açar)
Kaynak: Interact Cardiovasc Thorac Surg 2012;15(4):690-4.
İndeks: PubMed 22811512
DOI: 10.1093/icvts/ivs309
https://www.ncbi.nlm.nih.gov/pubmed/22811512 (yeni pencere açar)
Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency. (yeni pencere açar)
Kaynak: J Cardiothorac Vasc Anesth 2012;26(4):651-3.
İndeks: PubMed 21924639
DOI: 10.1053/j.jvca.2011.07.012
https://www.ncbi.nlm.nih.gov/pubmed/21924639 (yeni pencere açar)
Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. (yeni pencere açar)
Kaynak: J Cardiothorac Vasc Anesth 2011;25(6):987-94.
İndeks: PubMed 21835642
DOI: 10.1053/j.jvca.2011.05.012
https://www.ncbi.nlm.nih.gov/pubmed/21835642 (yeni pencere açar)
Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery. (yeni pencere açar)
Kaynak: J Clin Anesth 2014;26(3):204-11.
İndeks: PubMed 24809789
DOI: 10.1016/j.jclinane.2013.10.015
https://www.ncbi.nlm.nih.gov/pubmed/24809789 (yeni pencere açar)
Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery. (yeni pencere açar)
Kaynak: Asian Cardiovasc Thorac Ann 2012;20(1):19-23.
İndeks: PubMed 22371937
DOI: 10.1177/0218492311432584
https://www.ncbi.nlm.nih.gov/pubmed/22371937 (yeni pencere açar)
Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. (yeni pencere açar)
Kaynak: Pediatr Crit Care Med 2003;4(1):49-51.
İndeks: PubMed 12656542
DOI: 10.1097/01.PCC.0000031472.55687.4E
https://www.ncbi.nlm.nih.gov/pubmed/12656542 (yeni pencere açar)
Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. (yeni pencere açar)
Kaynak: J Intensive Care Med 2004;19(5):270-3.
İndeks: PubMed 15358945
DOI: 10.1177/0885066604267783
https://www.ncbi.nlm.nih.gov/pubmed/15358945 (yeni pencere açar)
Recombinant activated factor VII in cardiac surgery: a systematic review. (yeni pencere açar)
Kaynak: Ann Thorac Surg 2007;83(2):707-14.
İndeks: PubMed 17258029
DOI: 10.1016/j.athoracsur.2006.10.033
https://www.ncbi.nlm.nih.gov/pubmed/17258029 (yeni pencere açar)
Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here? (yeni pencere açar)
Kaynak: Pediatr Crit Care Med 2009;10(5):572-82.
İndeks: PubMed 19451849
DOI: 10.1097/PCC.0b013e3181a642d5
https://www.ncbi.nlm.nih.gov/pubmed/19451849 (yeni pencere açar)
Decreasing the need for transfusion: infant cardiac surgery using hemodilution and recombinant factor VIIa. (yeni pencere açar)
Kaynak: Pediatr Cardiol 2013;34(1):119-24.
İndeks: PubMed 22760694
DOI: 10.1007/s00246-012-0398-1
https://www.ncbi.nlm.nih.gov/pubmed/22760694 (yeni pencere açar)
Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (yeni pencere açar)
Kaynak: Pediatr Hematol Oncol 2008;25(4):301-11.
İndeks: PubMed 18484474
DOI: 10.1080/08880010802016904
https://www.ncbi.nlm.nih.gov/pubmed/18484474 (yeni pencere açar)
Pıhtılaşma Faktörü Konsantreleri
Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (yeni pencere açar)
Kaynak: Artif Organs 2010;34(11):955-60.
İndeks: PubMed 21092037
DOI: 10.1111/j.1525-1594.2010.01148.x
https://www.ncbi.nlm.nih.gov/pubmed/21092037 (yeni pencere açar)
Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. (yeni pencere açar)
Kaynak: Eur J Anaesthesiol 2014;31(6):317-26.
İndeks: PubMed 24503704
DOI: 10.1097/EJA.0000000000000043
https://www.ncbi.nlm.nih.gov/pubmed/24503704 (yeni pencere açar)
Efficacy and safety of fibrinogen concentrate in surgical patients: a meta-analysis of randomized controlled trials. (yeni pencere açar)
Kaynak: J Cardiothorac Vasc Anesth 2016;30(5):1196-204.
İndeks: PubMed 27493092
DOI: 10.1053/j.jvca.2016.04.015
https://www.ncbi.nlm.nih.gov/pubmed/27493092 (yeni pencere açar)
Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. (yeni pencere açar)
Kaynak: J Thorac Cardiovasc Surg 2014;148(4):1647-55.
İndeks: PubMed 24951020
DOI: 10.1016/j.jtcvs.2014.04.029
https://www.ncbi.nlm.nih.gov/pubmed/24951020 (yeni pencere açar)
Four-factor prothrombin complex concentrates in paediatric patients—a retrospective case series. (yeni pencere açar)
Kaynak: Vox Sang 2016;110(3):253-7.
İndeks: PubMed 26509839
DOI: 10.1111/vox.12353
https://www.ncbi.nlm.nih.gov/pubmed/26509839 (yeni pencere açar)
Desmopressin
Minimizing perioperative blood loss and transfusions in children. [Réduire les pertes sanguines et les besoins transfusionnels en chirurgie pédiatrique.] [English, French abstract] (yeni pencere açar)
Kaynak: Can J Anaesth 2006;53(6 Suppl):S59-67.
İndeks: PubMed 16766791
https://www.ncbi.nlm.nih.gov/pubmed/16766791 (yeni pencere açar)
Anesthetic management in a pediatric patient with Noonan syndrome, mastocytosis, and von Willebrand disease: a case report. (yeni pencere açar)
Kaynak: AANA J 2007;75(4):261-4.
İndeks: PubMed 17711156
https://www.ncbi.nlm.nih.gov/pubmed/17711156 (yeni pencere açar)
Topikal Hemostatik Ürünler
A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (yeni pencere açar)
Kaynak: Ann Surg 2010;251(2):217-28.
İndeks: PubMed 20010084
DOI: 10.1097/SLA.0b013e3181c3bcca
https://www.ncbi.nlm.nih.gov/pubmed/20010084 (yeni pencere açar)
Resternotomy in pediatric cardiac surgery: CoSeal initial experience. (yeni pencere açar)
Kaynak: Interact Cardiovasc Thorac Surg 2007;6(1):21-3.
İndeks: PubMed 17669759
DOI: 10.1510/icvts.2006.141531
https://www.ncbi.nlm.nih.gov/pubmed/17669759 (yeni pencere açar)
Cerrahiye ya da Pıhtılaşma Bozukluğuna Bağlı Kanamanın Tespitinde Viskoelastik Testler
Utility of Sonoclot analysis and tranexamic acid in tetralogy of Fallot patients undergoing intracardiac repair. (yeni pencere açar)
Kaynak: Ann Card Anaesth 2012;15(1):26-31.
İndeks: PubMed 22234018
DOI: 10.4103/0971-9784.91477
https://www.ncbi.nlm.nih.gov/pubmed/22234018 (yeni pencere açar)
Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (yeni pencere açar)
Kaynak: Artif Organs 2010;34(11):955-60.
İndeks: PubMed 21092037
DOI: 10.1111/j.1525-1594.2010.01148.x
https://www.ncbi.nlm.nih.gov/pubmed/21092037 (yeni pencere açar)
Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. (yeni pencere açar)
Kaynak: Br J Anaesth 2015;114(1):91-102.
İndeks: PubMed 25303988
DOI: 10.1093/bja/aeu339
https://www.ncbi.nlm.nih.gov/pubmed/25303988 (yeni pencere açar)